Ealixir, Inc. Fundamental Analysis
Ealixir, Inc. (EAXR) shows weak financial fundamentals with a PE ratio of 247.94, profit margin of 29.72%, and ROE of -2.72%. The company generates $0.0B in annual revenue with weak year-over-year growth of -28.25%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -244.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze EAXR's fundamental strength across five key dimensions:
Efficiency Score
ExcellentEAXR demonstrates superior asset utilization.
Valuation Score
ModerateEAXR shows balanced valuation metrics.
Growth Score
WeakEAXR faces weak or negative growth trends.
Financial Health Score
ModerateEAXR shows balanced financial health with some risks.
Profitability Score
WeakEAXR struggles to sustain strong margins.
Key Financial Metrics
Is EAXR Expensive or Cheap?
P/E Ratio
EAXR trades at 247.94 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, EAXR's PEG of -3.62 indicates potential undervaluation.
Price to Book
The market values Ealixir, Inc. at -257.37 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 895.11 times EBITDA. This signals the market has high growth expectations.
How Well Does EAXR Make Money?
Net Profit Margin
For every $100 in sales, Ealixir, Inc. keeps $29.72 as profit after all expenses.
Operating Margin
Core operations generate 8.13 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-2.72 in profit for every $100 of shareholder equity.
ROA
Ealixir, Inc. generates $16.82 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Ealixir, Inc. generates limited operating cash flow of $-256.62K, signaling weaker underlying cash strength.
Free Cash Flow
Ealixir, Inc. generates weak or negative free cash flow of $-257.58K, restricting financial flexibility.
FCF Per Share
Each share generates $-0.00 in free cash annually.
FCF Yield
EAXR converts -0.21% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
247.94
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-3.62
vs 25 benchmark
P/B Ratio
Price to book value ratio
-257.37
vs 25 benchmark
P/S Ratio
Price to sales ratio
73.69
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.57
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.91
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-2.72
vs 25 benchmark
ROA
Return on assets percentage
0.17
vs 25 benchmark
ROCE
Return on capital employed
-0.50
vs 25 benchmark
How EAXR Stacks Against Its Sector Peers
| Metric | EAXR Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 247.94 | 37.32 | Worse (Expensive) |
| ROE | -271.88% | 993.00% | Weak |
| Net Margin | 29.72% | 5975589423.00% | Weak |
| Debt/Equity | -1.57 | 0.41 | Strong (Low Leverage) |
| Current Ratio | 0.91 | 116.24 | Weak Liquidity |
| ROA | 16.82% | -297552.00% (disorted) | Strong |
EAXR outperforms its industry in 2 out of 6 key metrics, particularly excelling in ROA, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ealixir, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-99.94%
Industry Style: Growth, Innovation, High Beta
DecliningEPS CAGR
100.00%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
100.02%
Industry Style: Growth, Innovation, High Beta
High Growth